45,X/46,XX at amniocentesis associated with a favorable outcome and postnatal decrease of the 45,X cell line

Taiwan J Obstet Gynecol. 2022 Nov;61(6):1086-1087. doi: 10.1016/j.tjog.2022.08.009.
No abstract available

MeSH terms

  • Amniocentesis*
  • Cell Line
  • Female
  • Humans
  • Pregnancy
  • Prenatal Diagnosis*
  • Trisomy